Net Cash Provided by (Used in) Financing Activities of CYTOKINETICS INC from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
CYTOKINETICS INC annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • CYTOKINETICS INC Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $4,754,000, a 95% decline year-over-year.
  • CYTOKINETICS INC annual Net Cash Provided by (Used in) Financing Activities for 2025 was $524,458,000, a 44% decline from 2024.
  • CYTOKINETICS INC annual Net Cash Provided by (Used in) Financing Activities for 2024 was $930,611,000, a 320% increase from 2023.
  • CYTOKINETICS INC annual Net Cash Provided by (Used in) Financing Activities for 2023 was $221,317,000, a 57% decline from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

CYTOKINETICS INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $524,458,000 -$406,153,000 -44% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 $930,611,000 +$709,294,000 +320% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 $221,317,000 -$294,849,000 -57% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
2022 $516,166,000 +$196,186,000 +61% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $319,980,000 +$85,856,000 +37% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $234,124,000 +$74,333,000 +47% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
2019 $159,791,000 +$146,659,000 +1117% 01 Jan 2019 31 Dec 2019 10-K 25 Feb 2022 2021 FY
2018 $13,132,000 -$212,787,000 -94% 01 Jan 2018 31 Dec 2018 10-K 26 Feb 2021 2020 FY
2017 $225,919,000 01 Jan 2017 31 Dec 2017 10-K 07 Mar 2019 2018 FY
2013 $14,488,000 -$43,839,000 -75% 01 Jan 2013 31 Dec 2013 10-K 07 Mar 2014 2013 FY
2012 $58,327,000 +$36,714,000 +170% 01 Jan 2012 31 Dec 2012 10-K 07 Mar 2014 2013 FY
2011 $21,613,000 +$19,067,000 +749% 01 Jan 2011 31 Dec 2011 10-K 07 Mar 2014 2013 FY
2010 $2,546,000 01 Jan 2010 31 Dec 2010 10-K 15 Mar 2013 2012 FY

CYTOKINETICS INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $4,754,000 -$99,037,000 -95% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q1 2024 $103,791,000 +$110,968,000 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q1 2023 $7,177,000 -$101,023,000 -108% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q1 2022 $93,846,000 +$97,442,000 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023 2023 Q1
Q1 2021 $3,596,000 -$3,585,000 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022 2022 Q1
Q1 2020 $11,000* -$4,427,000 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021 2021 Q1
Q1 2019 $4,416,000 +$4,940,000 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q1 2018 $524,000 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q1 2014 $39,780,000 +$39,775,000 01 Jan 2014 31 Mar 2014 10-Q 07 May 2014 2014 Q1
Q1 2013 $5,000* -$2,662,000 01 Jan 2013 31 Mar 2013 10-Q 07 May 2014 2014 Q1
Q1 2012 $2,667,000 +$2,920,000 01 Jan 2012 31 Mar 2012 10-Q 08 May 2013 2013 Q1
Q1 2011 $253,000 01 Jan 2011 31 Mar 2011 10-Q 04 May 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.